| Name | Title | Contact Details |
|---|
LIFE Corporation is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to the Kansas economy in several ways. The company surpasses $1 billion in annual claims payments to health care providers and members and contributes more than $140 million a year to the economy through payroll and taxes. The company's headquarters are located in Topeka, KS. Nearly 1,400 employees work in the company's various office locations in Topeka. In addition, about 110 employees work in offices in Dodge City, Garden City, Hays, Hutchinson, Independence, Lawrence, Manhattan, Pittsburg, Salina and Wichita. BCBSKS is a member of the Blue Cross Blue Shield Association headquartered in Chicago. There are 36 Blue Cross and Blue Shield Plans throughout the United States. Each Plan is separate and independent but all Plans cooperate with other Blue Cross and Blue Shield Plans in the exchange of ideas, processing of claims and providing inter-plan services to customers.
We provide priority care to many counties throughout Northern and Southern California. Please use the map to the right, or the list below to browse our service coverage. We provide priority care to many counties throughout Northern and Southern
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Evidation Health is a technology and services company that helps individuals and the world`s most innovative healthcare companies understand and influence the everyday behaviors that create better health outcomes. Evidation pairs a first of its kind discovery engine designed for better, faster, and more efficient studies with a delivery platform that connects individuals and the healthcare industry, including life sciences organizations, providers, payers, and digital health companies. The company`s technology is designed to be entirely privacy-safe and individually-permissioned. Evidation Health`s mission is to enable and empower everyone to participate in better health outcomes. The company is headquartered in San Mateo, CA, with additional offices in Santa Barbara, CA.